NCT00145379View on ClinicalTrials.gov

The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

June 30, 2006

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Tablet Metformin 500 mg

DRUG

Placebo

Trial Locations (1)

5000

Diabetes Research Center, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT00145379 - The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter